Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Daniels believe that President Trump can use tariffs to ensure the US drug industry to work with democrats on the development of drugs.
President Donald Trump Recently, tariffs for pharmaceutical import and its leadership this week began the ramp this week.
The administration said that these tariffs need to return the pharmaceutical production as a national security issue as a matter of national security. This is a signal of supply chain AI, Exiger, an alarm on the reliability of the US pharmacy.
In the report of the Exiger’s report, “a painful pill: American drugs produced by America’s Chinese drugs”, the company is not under the existing system – with no risk of purchasing low quality medications.
President Donald Trump said he would target the pharmaceutical industry with tariffs. (Getty Images / Getty Images)
Trump admin moves towards the semiconductor, pharmaceutical tariffs
“We were very worried after the pandemic, the strategic national stockpiling efforts and restoration, in a kind of pharmacy, as well as the Echiger CEO Brandon Daniels fox worked. He said that those who rely on the elderly and critical general medicines, the existing pharmaceutical import system are the most.
According to Exiger, the United States currently imports 75% The main drugscomes from China and India with the majority. When India produces about half of common medicines, US imports, 80% of active pharmaceutical substances (API) are very confident for 80%. More than 500 total medicines, including diabetes and heart conditions and treatment tools for antibiotics, are trusting a country’s API.
Another factor that puts Americans under risk is the use of forced labor in the production of pharmaceutical products. Exigar, Sinopharm, Zhejiang Shindai Chemical Group and Zhejiang Chemistry Export Corp. Rely on Uyghur binding work in Xinjiang. It is expected to prevent goods prepared with the mandatory labor of the customs and border patrol; But some are still going through.
The company explains that the company in the Exiger’s report is the risk of taking low quality medicines in American patients or is nothing under the existing system. (ITOK / ISTOCK)
White House Trade Chief, Trump’s Tariff War No Plans to talk to xi jinping
Daniels spoke about the dangers involving Fox’s work Forced labor In the pharmaceutical industry, including ethics and product quality issues.
“Many of these sites found to be compelled to the forced labor, do not meet the good production process standards, dirty facilities, maps, without shoes,” Danish “on the maps of all the pharmaceutical information.
Exiger CEO referred to any incident of the transportation of drugs in hydrogen cyanid.
In an incident in 2023, the contaminated controls of extreme-eyed departments produced by India based Kilitch health, caused permanent vision and infections in some patients. According to the exiger’s report, the spotted items prepared by Kilitch Healthcare were used in the products of various brands.
In the report, Exiger recommends that the US strategic national drug, vaccine and facilities build a strategic team. In addition, the company calls on the United States to diversify the supply chains, to eliminate binding labor, strengthen FDA control and increase the production of domestic medicines.
Trump management said these tariffs need to return pharmaceutical production to the United States (Jeffrey Greenberg / Getty Images / Universal Images group via Getty Images)
“I think that when it comes to biotechnology, Daniels said that there is a way to produce more in the United States,” said Daniels fox. “And we still have a power in terms of intellectual property, but I do not think there will be the only answer.”
The trade department has launched an investigation into the results of national security of pharmaceutical imports on April 1 Federal Note Notice. The department said that this imports looked in other and other critical, medical medicines, medical effects and other critical components.
